STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS (Tables)

6 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Compensation Cost And Related Income Tax Benefits Recognized

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Operations for stock-based compensation plans were as follows:

	Three Months Ended December 31,				Six Months Ended December 31,
	2023		2022		2023		2022
Selling, general and administrative expenses	$	3,376	$	3,435	$	7,118	$	7,429
Related income tax benefit	$	398	$	552	$	854	$	954

Schedule of Non-Vested Restricted Stock And Restricted Share Unit Awards

A summary of the restricted stock activity (including all RSAs, RSUs and PSUs) for the six months ended December 31, 2023 is as follows:

	Number of Shares and Units	Weighted Average Grant Date Fair  Value (per share)
Non-vested RSAs, RSUs and PSUs outstanding at June 30, 2023	1,288	$	26.37
Granted	1,562	$	12.34
Vested	(479)	$	28.67
Forfeited	(114)	$	25.85
Non-vested RSAs, RSUs and PSUs outstanding at December 31, 2023	2,257	$	15.79

Schedule of Restricted Stock Grant Information

The fair value of RSAs, RSUs and PSUs granted and of shares vested, and the tax benefit recognized from restricted shares vesting was as follows:

	Six Months Ended December 31,
	2023		2022
Fair value of RSAs, RSUs and PSUs granted	$	19,286	$	21,457
Fair value of shares vested	$	5,081	$	3,317
Tax benefit recognized from restricted shares vesting	$	650	$	502

Schedule of Fair Value Assumptions

Grant date fair values are calculated using a Monte Carlo simulation model with grant date fair values per target share and related valuation assumptions as follows:

	Absolute TSR PSUs		Relative TSR PSUs
Grant date fair value (per target share)	$12.23		$15.42
Risk-free interest rate	4.98	%	4.98	%
Expected dividend yield	—		—
Expected volatility	33.70	%	23.10	%
Expected term	3.00 years		3.00 years